Xenetic Biosciences, Inc.
XBIO
$2.82
$0.02991.07%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -18.79% | 16.15% | -3.45% | 0.49% | 11.58% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -18.79% | 16.15% | -3.45% | 0.49% | 11.58% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -18.79% | 16.15% | -3.45% | 0.49% | 11.58% |
| SG&A Expenses | -41.79% | -21.36% | -25.87% | 1.15% | 19.45% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -36.32% | -13.69% | -9.32% | -36.65% | 11.61% |
| Operating Income | 45.84% | 25.70% | 12.47% | 56.44% | -11.62% |
| Income Before Tax | 45.94% | 24.43% | 9.99% | 58.63% | -21.22% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 45.94% | 24.43% | 9.99% | 58.63% | -21.22% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 45.94% | 24.43% | 9.99% | 58.63% | -21.22% |
| EBIT | 45.84% | 25.70% | 12.47% | 56.44% | -11.62% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 45.98% | 24.51% | 10.19% | 58.88% | -19.95% |
| Normalized Basic EPS | 45.99% | 24.50% | 10.19% | 58.89% | -19.96% |
| EPS Diluted | 45.98% | 24.51% | 10.19% | 58.88% | -19.83% |
| Normalized Diluted EPS | 45.99% | 24.50% | 10.19% | 58.89% | -19.96% |
| Average Basic Shares Outstanding | 0.08% | 0.09% | 0.22% | 0.59% | 1.06% |
| Average Diluted Shares Outstanding | 0.08% | 0.09% | 0.22% | 0.59% | 1.06% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |